1 North Waukegan Road
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.
2 Kingdom Street
Booth #: 04
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Tullastr. 8 - 12
Booth #: 08
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance cellular studies and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, optimize respiratory care and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 45,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit www.bd.com.
Bio-Kult Infantis (Protexin)
Booth #: 09
Bio-Kult Infantis is an advanced multi-strain formula for babies, toddlers and young children. Each easy to use sachet contains seven protected strains of live bacteria, proven to survive the high acidity of the stomach. The formula also contains Vitamin D3 to contribute to the normal function of the immune system, Preplex and DHA and EPA which are high in Omega 3 fatty acids. In a randomised controlled trial, the 7 bacterial strains were shown to significantly improve symptoms in infants suffering with colic. The formula does not contain artificial colours, flavours or preservatives and does not need to be refrigerated.
Chemin de l'Orme
Booth #: 10
Pioneering Diagnostics A world leader in the field of in vitro diagnostics for 50 years, bioMérieux is present in more than 150 countries through 42 subsidiaries and a large network of distributors. In 2015, revenues reached €1,965 million with 90% of sales outside of France. bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease to improve patient health. Its products are used for diagnosing infectious diseases. Know more: www.biomerieux.com
British Paediatric Surveillance Unit
Royal College of Paediatrics and Child Health, 5-11 Theobalds Road
Booth #: 01C
The British Paediatric Surveillance Unit (BPSU) was launched in 1986 to co-ordinate the collection of UK-wide data on rare childhood conditions and uncommon infections. The BPSU is a joint initiative of the Royal College of Paediatrics and Child Health, Public Health England, and the UCL-Institute of Child Health. The BPSU aims to encourage the study of rare conditions in children. Such conditions though individually uncommon collectively affect thousands of children, many seriously. Over its existence, the BPSU has facilitated and enabled paediatricians to participate in national epidemiological surveillance of rare childhood conditions.
François Versonnex 7
Booth #: 13
François Versonnex 7
Booth #: 13
would like to invite you to visit the ESPID Education booth that is organised
by the Education Committee. At the booth you will find a variety of online as
well as residential courses which are supported by ESPID. You may wish to enrol
yourself in one of the CPD accredited online courses: Antibiotic Management
Course, Paediatric HIV Training Course (Tr@inforPedHIV organised in
collaboration with PENTA) and a Vaccination Course (Wiser Immuniser organised
in collaboration with the World Health Organization). We also have the monthly
ESPID Case Rounds during which an interesting case is discussed amongst
trainees under the supervision of an expert. At the booth you will also find
information on all Paediatric Infectious Diseases courses that are organised in
several countries within Europe. Members of the Education Committee as well as
the organisers of the courses will be present at the booth. Do come and visit
us. We would be pleased to meet you and provide you with any course information
that you might be interested in.
11331 Valley View Street
Booth #: 11
Focus Diagnostics, Inc. manufactures and distributes molecular and serology products for use in hospitals and laboratories worldwide. Our Simplexa™ molecular menu include kits for HSV-1 & HSV-2; Flu A/B & RSV; Group A Strep; C. difficile; and more than 50 primer pairs, molecular controls, and reagents. All of our Direct assays, including Simplexa™ HSV 1 & 2 Direct, Simplexa™ Flu A/B & RSV Direct, and Simplexa™ Group A Strep Direct require no sample extraction and provide results in about an hour. Additional product lines include: HerpeSelect® type-specific serology and DxSelect™ ELISA and IFA products. Visit www.focusdx.com for more information.
St George's University of London
Booth #: 01B
GARPEC's core aim is to derive a simple global prospective antibiotic prescribing and antimicrobial resistance surveillance method for neonates and children. The specific aims of this project are: to compare global variation in antimicrobial prescribing practice and resistance using validated methods; to address critical gaps in our knowledge on global antimicrobial use, resistance and clinical outcomes. This project provides a platform to develop globally relevant initiatives addressing neonatal and paediatric infection prevention and control and antimicrobial stewardship.
GlaxoSmithKline Biologicals SA
Rue de l'Institut, 89
Booth #: 07
GSK is one of the world's leading vaccine companies, involved in vaccine research, development and production. We have 15 vaccines in development and our broad portfolio of 39 vaccines help prevent illnesses such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza and bacterial meningitis. Globally, we have more than 16,000 people working to deliver nearly 2 (1.9) million vaccines every day, to people in around 90% (172) of the world's countries. In 2015 we distributed around 690 million doses of vaccine, over 70% of them to least developed, low and middle income countries. For further information, please visit www.gsk.com.
UK/VAC/0051/16 Date of Preparation: April 2016
INGID : International Nursing Group for Immune Deficiencies
Booth #: 02B
The International Nursing Group for Immunodeficiencies (INGID) was formed in 1994 by nurses who were working with children and adults diagnosed with primary immunodeficiency disorders. INGID is run by members, for members. It is managed by a Board of experienced nurses in immunology who are volunteers and who are elected at the INGID conference that is held every 2 years in a different country. The General Meeting, open to all members and held during each Conference. The aims of INGID are to improve and extend the quality of nursing care of patients with primary immune deficiencies, and to increase the awareness and understanding of primary immunodeficiencies amongst nurses.
395 Hudson Street, 3rd FL
New York, NY
Medscape Education (medscape.org) targets and engages members across 33 healthcare specialties, and combines proprietary technology, instructional expertise, and measurable impact to accelerate the adoption of scientific advances in practice. Medscape Education is a leading online resource for continuing professional education (including independent activities provided by WebMD Global LLC), and continually innovates to better address clinician needs in order to improve the care and outcomes of patients.
Meridian Bioscience International Ltd
16 Edge Business Centre
Booth #: 12
Meridian Bioscience manufactures kits for the early diagnosis of gastrointestinal, respiratory, sexually transmitted, neonatal and newly added blood borne parasitic infections (Malaria). Our diagnostic tests aid clinicians in the appropriate management of patients with acute infections. New extensions to the illumigene molecular range include two assay options for Malaria. illumigene Malaria offers our customers high levels of sensitivity with unparalleled ease-of-use on our rapid, molecular platform. Recent additions also include HSV 1&2. We invite you to speak with our experts and learn how Meridian can benefit your laboratory, your budget and healthcare setting
Meningitis Research Foundation
Newminster House, Baldwin Street
Booth #: 01A
Research Foundation has been at the forefront of the fight against meningitis
and septicaemia for over 25 years. Our vision is of a world free from
meningitis and septicaemia. A registered charity, with staff in the UK, Ireland
and Malawi, we have invested over £18.9 million in vital research to prevent, diagnose
and treat these diseases. We spend £1m a year supporting people affected,
raising awareness and promoting best practice in treatment. We are building on
our track record of significant support for research outside the UK and Ireland
while developing new models to tackle the diseases globally.
20 Firstfield Road
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and adjuvant technology are the foundation for ground-breaking innovation that improves global health through safe and effective vaccines. Our product pipeline targets a variety of infectious diseases with vaccine candidates currently in clinical development for respiratory syncytial virus (RSV), seasonal influenza, pandemic influenza, and Ebola virus (EBOV). We also have additional preclinical stage programs, including the Middle East. Novavax is headquartered in Gaithersburg, Maryland with additional facilities in Rockville, Maryland and Uppsala, Sweden.
Orion Diagnostica Oy
Koivu-Mankkaan tie 6 B
Booth #: 10A
Orion Diagnostica has over 40 years' experience in diagnostic test systems for doctor's offices, healthcare centres and laboratories. Orion Diagnostica's QuikRead go® system is the fastest point-of-care test method for measuring C-reactive protein (CRP) in fingertip or venous blood samples. This system simplifies the daily routines of healthcare professionals. CRP is very useful in targeting antibiotic use and thus helping to reduce the growth of antibiotic resistance, one of the most serious healthcare concerns faced today. QuikRead go® offers reliable results in minutes with CRP, CRP+Hb, Strep A and iFOBT tests.
Pediatric Infectious Diseases Society
1300 Wilson Blvd, Ste 300
Booth #: 03
PIDS membership encompasses leaders across the global scientific and public health spectrum, including clinical care, advocacy, academics, government, and the pharmaceutical industry. From fellowship training to continuing medical education, research, regulatory issues and guideline development, PIDS members are the core professionals advocating for the improved health of children with infectious diseases both nationally and around the world, participating in critical public health and medical professional advisory committees that determine the treatment and prevention of infectious diseases, immunization practices in children, and the education of pediatricians.
235 East 42nd St.
Booth #: 05
Pfizer International Operations
23-25 ave du Dr Lannelongue
Rives de Paris
Booth #: 05
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.
Public Health England
61 Colindale Avenue Colindale
Booth #: 01
PHE Immunisation Information Immunisation is the single most effective way to protect children, teenagers and adults against infectious diseases. Public Health England publishes an extensive range of materials on immunisation, for individuals, parents and health professionals. We are delighted to be here at ESPID. Immunisation is a fast moving area and the challenges of the new programmes affect health professionals who immunise in many ways and we want to showcase the materials that we provide here in England. Make sure you visit our stand see what's new in Immunisation today, we look forward to welcoming you.
Sanofi Pasteur MSD
162 avenue Jean jaures
Booth #: 06
Building upon the legacy of pioneers like Louis Pasteur we want to help protect people against infectious diseases so that they can live longer, feel better and achieve more. We are dedicated exclusively to vaccines because we believe prevention is better than cure and immunisation is the best prevention. Our 45 vaccines help protect people from 20 infectious diseases, including cervical cancer, liver cancer, tuberculosis, poliomyelitis, rabies, measles, yellow fever, shingles and influenza. Our vaccines help protect everyone throughout life –from infancy to old age. Sanofi Pasteur MSD is a joint venture between sanofi pasteur - the vaccine division of sanofi-aventis - and Merck & Co. Inc.. We develop, license, market and distribute vaccines in Western Europe. We lead the vaccine industry in Western Europe.
Wisepress Medical Bookshop
25 High Path
Booth #: 2
Wisepress.com, Europe's leading conference bookseller, has a range of books and journals relevant to the themes of the meeting. In addition to attending 200 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers. Follow us on Twitter for the latest news @WisepressBooks.